Thoracic Surgery

Medicine & Life Sciences

1. Lung 100%
2. Lung Transplantation 62%
3. Video-Assisted Thoracic Surgery 52%
4. Chronic Obstructive Pulmonary Disease 45%
5. Lung Neoplasms 45%
6. Thymectomy 44%
7. Allografts 40%
8. Sternotomy 40%
9. Pneumonectomy 36%
10. Pneumonia 34%
11. Chest Tubes 34%
12. Neoplasms 31%
13. Transplants 31%
14. Thoracic Surgery 31%
15. Thoracic Cavity 28%
16. persulfides 26%
17. Thorax 24%
18. Bronchoscopy 24%
19. isoprene 22%
20. Lymphangioleiomyomatosis 22%
21. Mucinous Cystadenocarcinoma 21%
22. Scedosporium 21%
23. Pulmonary Hypertension 21%
24. Bronchiolitis Obliterans 21%
25. Thoracotomy 20%
26. Growth Differentiation Factors 20%
27. Factor XI 20%
28. CTLA-4 Antigen 19%
29. polysulfide 19%
30. Bronchiolitis 19%
31. Chylothorax 19%
32. Frozen Sections 19%
33. Elderly 19%
34. Intercostal Nerves 18%
35. Continuous Renal Replacement Therapy 18%
36. Large Cell Carcinoma 18%
37. Pleurodesis 18%
38. Therapeutics 18%
39. Postoperative Cognitive Complications 17%
40. Fibrin Tissue Adhesive 17%
41. Transplantation 17%
42. Thymoma 17%
43. Pulmonary Atelectasis 16%
44. Lymph Nodes 16%
45. Acetone 16%
46. Pulmonary Arterial Hypertension 16%
47. Critical Care 16%
48. Learning Curve 16%
49. Cognition 16%
50. Carcinoid Tumor 16%
51. Poly C 16%
52. polyglucosan 15%
53. Methylprednisolone 15%
54. Squamous Cell Carcinoma 15%
55. Recurrence 15%
56. General Anesthesia 15%
57. Graft Rejection 15%
58. Sarcoidosis 15%
59. Pneumothorax 15%
60. Transplant Recipients 15%
61. Blood Vessels 15%
62. Drug Therapy 15%
63. Granulocyte Colony-Stimulating Factor 15%
64. Adenocarcinoma of Lung 15%
65. Interleukin-17 14%
66. Ethics 14%
67. Cognitive Dysfunction 14%
68. Pulmonary Artery 14%
69. Glass 13%
70. Hematoma 13%
71. Natural Killer Cells 13%
72. Mesenchymal Stem Cells 12%
73. Dyspnea 12%
74. Non-Small Cell Lung Carcinoma 12%
75. Tomography 12%
76. Smooth Muscle Myocytes 12%
77. Reading 12%
78. Aorta 12%
79. Bronchi 12%
80. Stents 12%
81. Postoperative Complications 12%
82. Mediastinum 11%
83. Drainage 11%
84. Pathologic Constriction 11%
85. Swine 11%
86. Adenocarcinoma 11%
87. Adenosine Triphosphate 10%
88. Emergencies 10%
89. Epithelium 10%
90. Randomized Controlled Trials 10%
91. Carcinoembryonic Antigen 10%
92. Quality of Life 10%
93. Air 10%
94. Micafungin 10%
95. University Hospitals 9%
96. Stroke 9%
97. Injections 9%
98. Carcinoma 9%
99. Survival Rate 9%
100. Control Groups 9%